Wuxi No. 4 People's Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Wuxi China (1976)

Organization Overview

First Clinical Trial
2011
NCT01404260
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Wuxi No. 4 People's Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Carcinoma (Phase 3)

Carcinoma, Bronchogenic (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 3)

Head and Neck Neoplasms (Phase 1)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 1)

Neoplasms (Phase 1)

Prostatic Neoplasms (Phase 1)

Soft Tissue Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 11